Status | Study |
Completed |
Study Name: Standard Length Catheters vs Long Catheters in Peripheral Vein Cannulation. Condition: Complications Date: 2013-08-05 Interventions: Device: Standard Device for peripheral vein cannulation |
Active, not recruiting |
Study Name: Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF Condition: Atrial Fibrillation Date: 2013-03-18 Interventions: Drug: Amiodarone patients will be randomly assigned to oral OR IV Amiodarone |
Suspended |
Study Name: Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children Condition: Infection of Intravenous Catheter Phlebitis Date: 2013-01-29 Interventions: Drug: 0,9% NaCl flush Normal S |
Completed |
Study Name: Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis Condition: Venous Thrombosis Postthrombotic Syndrome Date: 2011-11-28 Interventions: Procedure: CDT+US group CDT us |
Completed |
Study Name: Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Condition: Superficial Thrombophlebitis Date: 2010-11-22 Interventions: Drug: Dalteparin dalteparin 50 |
Completed |
Study Name: Effectiveness of Topical Glycerine Sulphate Paste, Hirudoid Cream and Nil Application on Superficial Phlebitis Condition: Infection Date: 2010-10-20 Interventions: Drug: Glycerine Magnesium sulphate paste |
Completed |
Study Name: Heparin 100U/L for Prevention of PVC Complications Condition: Peripheral Venous Catheter Complications Occlusion Date: 2010-05-26 Interventions: Other: heparin 100U/L flushes peripheral venous catheter flushing with 3 mL of a 100 U heparin/mL normal |
Completed |
Study Name: Use of Chamomilla Recutita in Phlebitis Condition: Phlebitis Date: 2009-10-02 Interventions: Other: compress of Chamomilla recutita infusion |
Completed |
Study Name: Epidemiology of Thromboembolism Disease: A Cohort Study Condition: Vascular Diseases Embolism and Thrombosis Date: 2008-04-30 Interventions: Other: procedure of Deep Vein Thrombosis (DVT) and PE (Pulmonary Embolism) diagnosis patients with a cli |
Completed |
Study Name: Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) Condition: Thrombosis, Venous Date: 2007-03-02 Interventions: Drug: Fondaparinux 2.5mg or placebo Fondaparinux 2.5mg or matching placebo subcutaneously once daily up |